Jon Congleton
Overview
Jon Congleton received an average of $4M in total compensation, including $467K in salary, at Mineralys Therapeutics between 2022 and 2023. Jon Congleton also received an average of $2M at Nivalis Therapeutics from 2015 to 2017.
- 2023
- 2022
- 2017
- 2016
- 2015
Mineralys TherapeuticsChief Executive Officer
Mineralys TherapeuticsChief Executive Officer
Nivalis TherapeuticsFormer President and Chief Executive Officer
Nivalis TherapeuticsFormer President and Chief Executive Officer
Nivalis TherapeuticsChief Executive Officer and President
Source: SEC filings on April 9, 2024, April 24, 2018, and March 21, 2016.
Related executives
We found nine more executives who work or worked at Mineralys Therapeutics and Nivalis Therapeutics.
David Rodman
Mineralys Therapeutics
Chief Medical Officer
Adam Levy
Mineralys Therapeutics
Chief Financial Officer
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
Stanford Peng
Nivalis Therapeutics
President and Head of Research and Development
Zelanna Goldberg
Nivalis Therapeutics
Chief Medical Officer
Paul Rickey
Nivalis Therapeutics
Chief Financial Officer
Mark Litton
Nivalis Therapeutics
Chief Operating Officer
Janice Troha
Nivalis Therapeutics